Overview
Tatsuya Nakagawa practices practicing medicine in Kyotanabe, Japan.
Mr. Nakagawa is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Macular Corneal Dystrophy Type 1 and Fuchs Dystrophy.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tatsuya Nakagawa
Is Tatsuya Nakagawa a top-rated expert for Macular Corneal Dystrophy Type 1?
MediFind is an objective health platform that identifies experts based on real-world data. Tatsuya Nakagawa is classified as an Elite expert for Macular Corneal Dystrophy Type 1, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tatsuya Nakagawa participate in research or clinical trials?
Yes. Tatsuya Nakagawa has published 11 articles and abstracts on conditions like Macular Corneal Dystrophy Type 1. You can view a list of Tatsuya Nakagawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Fuchs DystrophyMr. Nakagawa isElite. Learn about Fuchs Dystrophy.
- Macular Corneal Dystrophy Type 1